These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 24060648)

  • 1. Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice.
    Moroto M; Nishimura A; Morimoto M; Isoda K; Morita T; Yoshida M; Morioka S; Tozawa T; Hasegawa T; Chiyonobu T; Yoshimoto K; Hosoi H
    Brain Res; 2013 Nov; 1537():319-26. PubMed ID: 24060648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postnatal changes in serotonergic innervation to the hippocampus of methyl-CpG-binding protein 2-null mice.
    Isoda K; Morimoto M; Matsui F; Hasegawa T; Tozawa T; Morioka S; Chiyonobu T; Nishimura A; Yoshimoto K; Hosoi H
    Neuroscience; 2010 Feb; 165(4):1254-60. PubMed ID: 19932741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of postsynaptic GABAA and extrasynaptic NMDA receptor-mediated responses in the barrel cortex of Mecp2-null mice.
    Lo FS; Blue ME; Erzurumlu RS
    J Neurophysiol; 2016 Mar; 115(3):1298-306. PubMed ID: 26683074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome.
    Santos M; Summavielle T; Teixeira-Castro A; Silva-Fernandes A; Duarte-Silva S; Marques F; Martins L; Dierssen M; Oliveira P; Sousa N; Maciel P
    Neuroscience; 2010 Oct; 170(2):453-67. PubMed ID: 20633611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional differences in the barrel cortex of Mecp2 null mice.
    Lee LJ; Tsytsarev V; Erzurumlu RS
    J Comp Neurol; 2017 Dec; 525(18):3951-3961. PubMed ID: 28857161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin.
    Villani C; Sacchetti G; Carli M; Invernizzi RW
    Neuropharmacology; 2020 Oct; 176():108221. PubMed ID: 32652084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome.
    Nag N; Mellott TJ; Berger-Sweeney JE
    Brain Res; 2008 Oct; 1237():101-9. PubMed ID: 18778693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain.
    Braunschweig D; Simcox T; Samaco RC; LaSalle JM
    Hum Mol Genet; 2004 Jun; 13(12):1275-86. PubMed ID: 15115765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental abnormalities of cortical interneurons precede symptoms onset in a mouse model of Rett syndrome.
    Tomassy GS; Morello N; Calcagno E; Giustetto M
    J Neurochem; 2014 Oct; 131(1):115-27. PubMed ID: 24978323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of adenosinergic system in Rett syndrome: Novel therapeutic target to boost BDNF signalling.
    Miranda-Lourenço C; Duarte ST; Palminha C; Gaspar C; Rodrigues TM; Magalhães-Cardoso T; Rei N; Colino-Oliveira M; Gomes R; Ferreira S; Rosa J; Xapelli S; Armstrong J; García-Cazorla À; Correia-de-Sá P; Sebastião AM; Diógenes MJ
    Neurobiol Dis; 2020 Nov; 145():105043. PubMed ID: 32798727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
    Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.
    Kondo M; Gray LJ; Pelka GJ; Christodoulou J; Tam PP; Hannan AJ
    Eur J Neurosci; 2008 Jun; 27(12):3342-50. PubMed ID: 18557922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
    Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for abnormal early development in a mouse model of Rett syndrome.
    Santos M; Silva-Fernandes A; Oliveira P; Sousa N; Maciel P
    Genes Brain Behav; 2007 Apr; 6(3):277-86. PubMed ID: 16848781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
    Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
    Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.
    Viola A; Saywell V; Villard L; Cozzone PJ; Lutz NW
    PLoS One; 2007 Jan; 2(1):e157. PubMed ID: 17237885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome.
    Kao FC; Su SH; Carlson GC; Liao W
    Brain Struct Funct; 2015 Jan; 220(1):419-34. PubMed ID: 24218106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.